Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MTNR1B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
XCR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
GEO DataSets Gene Profile neighbors Chromosome neighbors
FOXN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C11orf57 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM220 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LCN8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CNBD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC285957 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
COL19A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC388692 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OIT3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TBCEL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PELO - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on